Organic Letters
Letter
Scheme 3. Alternative Synthetic Route to Neu4,5,7,8,9(Ac)5
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
This work is supported by the National Institutes of Health, NIH
Grant No. R01GM090262. NSF CRIF program (CHE -
■
9
808183), NSF Grant No. OSTI 97-24412, and NIH Grant
No. RR11973 provided funding for the NMR spectrometers used
on this project. We thank Dr. Jerry Dallas (University of
California, Davis) for help with the long-range HMBC NMR
experiments and 2D NMR experiments.
REFERENCES
■
(
1
1) Byrne, G.; Donohoe, G.; O’Kennedy, R. Drug Discov. Today 2007,
2, 319−326.
(
(
(
2) Chen, X.; Varki, A. ACS Chem. Biol. 2010, 5, 163−179.
3) Kiefel, M.; Von Itzstein, M. Chem. Rev. 2002, 102, 439−469.
4) Fukuda, M. In Molecular and Cellular Glycobiology; Oxford
These experimental findings show unique expansion of ReSET
toward structurally complex sugars like Neu5Ac while demon-
strating a facile preparation of naturally occurring O-acetylated
Neu5Ac analogues in the highest yields to date (Table 3). In
University Press: New York, 2000; pp 33−44.
(
(
(
5) Feizi, T. Immunol. Rev. 2000, 173, 79−88.
6) Angata, T.; Varki, A. Chem. Rev. 2002, 102, 471−490.
7) Kelm, S.; Schauer, R. Int. Rev. Cytol. 1997, 175, 137−240.
Table 3. Summary of Previous and Current Syntheses of
Naturally Occurring O-Acetylated Neu5Ac
(8) Engstler, M.; Schauer, R.; Brun, R. Acta. Trop. 1995, 59, 117−129.
(9) Schauer, R.; Srinivasan, G.; Wipfler, D.; Kniep, B.; Schwartz-Albiez,
R. Adv. Exp. Med. Biol. 2011, 705, 525−548.
(10) Schauer, R. Zoology 2004, 107, 49−64.
(11) Iwersen, M.; Dora, H.; Kohla, G.; Gasa, S.; Schauer, R. Biol. Chem.
2
(
003, 384, 1035−1047.
12) Clarke, P.; Mistry, N.; Thomas, G. Org. Biomol. Chem. 2012, 10,
5
(
(
29−535.
13) De Meo, C.; Priyadarshani, U. Carbohydr. Res. 2008, 1540−1552.
14) Khedri, Z.; Muthana, M.; Li, Y.; Muthana, S.; Yu, H.; Cao, H.;
Chen, X. Chem. Commun. 2012, 48, 3357−3359.
15) Hasegawa, A.; Murase, T.; Ogawa, M.; Ishida, H.; Kiso, M. J.
Carbohydr. Chem. 1990, 9, 415.
16) Witschi, M.; Gervay-Hague, J. Org. Lett. 2010, 12 (19), 4312−
315.
17) Hsieh, H.-W.; Schombs, M.; Witschi, M.; Gervay-Hague, J. J. Org.
Chem. 2013, 78, 9677−9688.
18) (a) Wender, P.; Verma, V.; Paxton, T.; Pillow, T. Acc. Chem. Res.
008, 41, 40−49. (b) Newhouse, T.; Baran, P.; Hoffmann, R. Chem. Soc.
Rev. 2009, 38, 3010−3021. (c) Wender, P.; Miller, B. Nature 2009, 460,
(
(
4
(
(
2
1
(
(
97−201.
19) Bhat, A.; Gervay-Hague, J. Org. Lett. 2001, 3, 2081−2084.
20) Schombs, M.; Park, F.; Du, W.; Kulkarni, S.; Gervay-Hague, J. J.
addition to reducing the chemical reaction steps, time efficiency
was increased by >75% compared to previous reports and the
chemicals used for this reaction were reduced to approximately
Org. Chem. 2010, 75, 4891.
(21) Sweeley, C.; Bentley, R.; Makita, M.; Wells, W. J. Am. Chem. Soc.
1963, 85, 2497−2507.
(22) Du, W.; Kulkarni, S.; Gervay-Hague, J. Chem. Commun. 2007,
50% (Table 3). Given our efforts to conserve valuable resources
2
(
336−2338.
in the chemical research setting, this study validates ReSET as a
step-, chemical-, and time- economical synthetic methodology.
Analogues from ReSET may be used for future carbohydrate-
based drug designs or as suitable standards that can expand the
understanding of biology, immunology, and chemical functions.
23) Davis, R.; Lin, C.; Gervay-Hague, J. Chem. Commun. 2012, 48,
9
(
(
083−9085.
24) Ikawa, T.; Sajiki, H.; Hirota, K. Tetrahedron 2004, 6901−6911.
25) Kenkyusho, N. Japanese patent 09-249682, Sep 22, 1997.
ASSOCIATED CONTENT
■
*
S
Supporting Information
5
047
dx.doi.org/10.1021/ol502389g | Org. Lett. 2014, 16, 5044−5047